Added to YB: 2026-05-19
Pitch date: 2026-05-16
PGNY [bullish]
Progyny, Inc.
+5.9%
current return
Author Info
No bio for this author
Company Info
Progyny, Inc., a benefits management company, provides fertility, family building, and women’s health benefits solutions in the United States.
Market Cap
$1.8B
Pitch Price
$23.23
Price Target
46.00 (+87%)
Dividend
N/A
EV/EBITDA
14.29
P/E
30.42
EV/Sales
1.26
Sector
Health Care Providers and Services
Category
growth
Progyny (PGNY): A Pure-Play on One of Society's Biggest Problems
PGNY: Fertility benefits manager at 1.1x sales, 17x 2026E EPS, ~15% 3yr IRR to $46 fair value. $1.29B rev (+20% ex-lost client), 17.2% EBITDA margin, $310M net cash. Completed $200M buyback, evaluating new authorization. Trump admin proposed 'limited excepted benefits' rule w/ $120K lifetime cap for fertility coverage - key regulatory tailwind. Progyny Select (launched Apr 2026) opens 50M-employee small-employer market for 2027 plan year. Q1 beat, raised FY26 guide. Risks: client concentration, engagement variability, competition. Demographic tailwind (declining OECD fertility rates, later pregnancies) + political support create durable structural demand.
Read full article (13 min)